Dr. T Lynn Warthan, MD

Dr. Warthan practices at Warthan Dermatology Nacogdoches in Nacogdoches, Texas.

Dr. Warthan's NPI, 1679647317, was assigned on November 17, 2006. Dr. Warthan graduated from UTMB Health in 1971. Dr. Warthan holds Texas license D8472.

Dr. Warthan's primary practice is Warthan Dermatology Nacogdoches, at 4730 Ne Stallings Dr, Nacogdoches, TX 75965-1615. The practice phone is (936) 564-6107.

Dr. Warthan's primary practice is Warthan Dermatology Nacogdoches in Nacogdoches, Texas. The medical group on file is Warthan Dermatology Center of Nacogdoches.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Warthan practices. Vendor and product names are available with a free account.

Dermatology is Dr. Warthan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Warthan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Warthan's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Warthan treats.

CMS data shows 6,293 Medicare services from Dr. Warthan across 31 procedure codes in 2024, for 892 Medicare patients. Medicare paid $428,334 for them. Every service was in an office.

CMS counts 892 Medicare patients who saw Dr. Warthan in 2024. The largest group is 75 to 84, with 387 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Warthan's median patient age at 74, with 49% women.

In 2024, Dr. Warthan wrote 218 Medicare Part D claims for 114 patients. 95% of them were for generic drugs. CMS names the drug for 118 of them, across 5 drugs with 11 or more claims each, at $2,675 in total drug cost. In 2023, CMS named 101 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Warthan for performance year 2024, reported as part of a group. Dr. Warthan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 175 procedures of melanoma (skin cancer) excision by Dr. Warthan, more than 97% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Warthan. The most frequent topics are Administration, Topical. Dr. Warthan has published most often in Arch Dermatol. Dr. Warthan's most frequent co-authors are Aaron C. Polk, MD and Mandy Lynn Warthan, MD.

CMS Open Payments shows 118 general payments to Dr. Warthan from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $514.

Dr. Warthan graduated from UTMB Health in 1971.

Dr. Warthan is in network with 21 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.